Philipp Weißkamp

Associate

Düsseldorf + 49.211.5406.5568

Philipp Weißkamp's practice focuses on advising national and international clients on domestic and cross-border M&A transactions, private equity matters regarding the purchase or sale of corporate entities or shares, as well as general corporate matters.

Prior to earning his second state exam, Philipp served as a research associate and law clerk in the areas of financial markets, mergers and acquisitions, and corporate for several years. He also gained practical experience in M&A and corporate matters for a leading German law firm in Düsseldorf.

Experience

  • Mandarin Oriental Hotel Group sells Munich hotel to Eagle HillsJones Day advised Mandarin Oriental Hotel Group in the sale of the Mandarin Oriental Hotel Munich to Eagle Hills, a private real estate investment and development company based in Abu Dhabi, and to manage the hotel for Eagle Hills under the Mandarin Oriental brand.
  • Belfius Bank and ING Belgium finance acquisition of Intersoft Electronics Group by IDIJones Day acted as legal counsel to Belfius Bank SA/NV and ING Belgium in connection with the financing for the acquisition of the Intersoft Electronics Group by IDI.
  • GIMV invests in AmbulantisJones Day advised GIMV in the acquisition of a significant stake in Ambulantis, a fast-growing care provider with a focus on outpatient care in assisted living facilities and day care.
  • TotalEnergies acquires VSB Group for €1.57 billionJones Day advised TotalEnergies in the €1.57 billion (equity value) acquisition of VSB Group, a Germany based renewable energy developer and operator of wind farms and photovoltaic power plants in Germany, France, Italy, Poland, Finland, and Croatia, from Swiss asset manager Partners Group.
  • National bank provides $115 million senior secured credit facility to global manufacturer of specialty paper and packaging solutionsJones Day represented a national bank, as administrative agent and left lead arranger, in connection with a $115 million senior secured credit facility, consisting of a $55 million asset-based revolving credit facility, a $39 million mortgage-backed term loan facility, and a $21 million term loan facility, provided to a global manufacturer of specialty paper and packaging solutions.
  • Belfius Bank, ING Belgium, KBC Bank, and Caisse d'Epargne et de Prévoyance Hauts de France amend and increase existing financing to Equine Care GroupJones Day acted as counsel to Belfius Bank SA/NV, ING Belgium NV/SA, KBC Bank NV, and Caisse d'Epargne et de Prévoyance Hauts de France, as lenders, in connection with the amendment and increase of the existing financing granted to the Equine Care Group, an international provider of high-quality equine care through specialist equine clinics, ambulatory care,and nutrition/supplements, for the purpose of, amongst others, acquiring the Belgian companies Roose BV and Westpaille BV.
  • Nordson Corporation increases revolving credit facility by $72.5 millionJones Day represented Nordson Corporation in connection with an amendment to increase the commitments of its revolving credit facility with Wells Fargo Bank, National Association, as agent, by $72.5 million, bringing the total amount available under the facility to $922.5 million.
  • Bank of America, Barclays, BNP Paribas, Deutsche Bank, Goldman Sachs, JPMorgan, Morgan Stanley, Royal Bank of Canada, and SMBC provide multi-billion euro financing for Blackstone’s Mileway logistics platformJones Day represented Bank of America, Barclays, BNP Paribas, Deutsche Bank, Goldman Sachs, JPMorgan, Morgan Stanley, Royal Bank of Canada, and SMBC in connection with the provision of multi-billion euro senior secured term and revolving credit facilities for Blackstone’s Mileway logistics platform.
  • Belfius Bank, ING Belgium, and KBC Bank amend, increase, and extend existing financing to Equine Care GroupJones Day acted as counsel to Belfius Bank SA/NV, ING Belgium NV/SA and KBC Bank NV, as lenders, in connection with the amendment, increase, and extension of the existing financing granted to the Equine Care Group (an international provider of high-quality equine care through specialist equine clinics, ambulatory care and nutrition/supplements) for the purpose of, amongst others, acquiring the Irish company Thoroughbred Remedies Manufacturing Limited and the English company Equine Products U.K. Limited.